Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
Suzanne Skoda-Smith, Troy R Torgerson, Hans D OchsSeattle Children’s Research Institute and Department of Pediatrics, University of Washington, Seattle, WashingtonAbstract: Antibody deficiency is the most frequently encountered primary immunodeficiency disease (PIDD) and patients who l...
Main Authors: | Suzanne Skoda-Smith, Troy R Torgerson, Hans D Ochs |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-12-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/subcutaneous-immunoglobulin-replacement-therapy-in-the-treatment-of-pa-a3834 |
Similar Items
-
Immunoglobulin replacement therapy for primary immunodeficiencies.
by: Peter, J, et al.
Published: (2014) -
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
by: Kobrynski L
Published: (2012-08-01) -
A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
by: Kristin Epland, et al.
Published: (2022-09-01) -
Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
by: Jolles S
Published: (2013-09-01) -
Subcutaneous immunoglobulin replacement therapy: the European experience.
by: Chapel, H, et al.
Published: (2013)